Carnegie, PA, United States of America

Michelle L Ratay

This inventor holds 2 USPTO granted patents. Top assignee: University of Pittsburgh. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle L Ratay. Retrieved from https://idiyas.com/inventor/michelle-l-ratay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michelle L Ratay: Innovator in Ocular Treatment

Introduction

Michelle L Ratay is a prominent inventor based in Carnegie, PA (US). She has made significant contributions to the field of ocular treatment, holding two patents that focus on innovative methods for addressing ocular disorders. Her work is vital in advancing therapeutic options for patients suffering from various eye conditions.

Latest Patents

Michelle's latest patents include a method for treating ocular conditions utilizing a histone/protein deacetylase inhibitor. This method involves administering a therapeutic agent-loaded carrier to an ocular site of a subject in need, wherein the therapeutic agent is a histone deacetylase inhibitor. This innovative approach aims to improve treatment outcomes for individuals with ocular disorders.

Career Highlights

Michelle L Ratay is affiliated with the University of Pittsburgh, where she continues to engage in research and development in her field. Her academic background and professional experience have positioned her as a leader in ocular treatment innovations.

Collaborations

Michelle collaborates with Steven R Little, enhancing her research efforts and contributing to the advancement of ocular therapies.

Conclusion

Michelle L Ratay's work in developing innovative treatments for ocular conditions showcases her dedication to improving patient care through scientific research and invention. Her contributions are paving the way for future advancements in ocular health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…